Disease on EC 3.2.1.21 - beta-glucosidase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Aberrant Crypt Foci
Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice.
Adenocarcinoma
Alteration in glycosidases from well-differentiated colorectal adenocarcinoma of rat.
adenylate cyclase deficiency
Enzymatic alterations secondary to adenyl cyclase deficiency in the cr-1 (crisp) mutant of Neurospora crassa: anomalies of the beta-glucosidase system.
Agranulocytosis
Pharmacologic manipulation of the murine pulmonary biochemical response to NO2.
alpha-galactosidase deficiency
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Anemia
Gaucher disease type 1: the first experience of enzyme replacement therapy in pediatric practice in Moldova - case report.
Arthritis
Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?
Arthritis, Juvenile
Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?
arylsulfatase (type i) deficiency
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
beta-galactosidase deficiency
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
beta-glucosidase deficiency
An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
beta-glucosidase deficiency
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
beta-glucosidase deficiency
In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.
beta-glucosidase deficiency
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
beta-glucosidase deficiency
Progressive myoclonic epilepsy due to Gaucher's disease in an adult.
beta-glucosidase deficiency
[Adult-type Gaucher's disease: an histochemical study of one case (author's transl)]
beta-glucosidase deficiency
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Brucellosis
[Immunogenic properties of emulsin vaccine against paratyphoid and brucellosis in sheep]
Carcinogenesis
Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.
Carcinogenesis
Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis.
Carcinogenesis
Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on fecal enzymes in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Carcinoma
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Carcinoma, Hepatocellular
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Carcinoma, Lewis Lung
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Coccidioidomycosis
A seroreactive 120-kilodalton beta-1,3-glucanase of Coccidioides immitis which may participate in spherule morphogenesis.
Colitis
T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model.
Colonic Neoplasms
Possible contribution of beta-glucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells.
Colonic Neoplasms
The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon.
Colorectal Neoplasms
Characterization of beta-glucosidase and beta-glucuronidase of alkalotolerant intestinal bacteria.
Coronary Disease
[The use of biochemical indices in the prognosis and diagnosis of ischemic heart disease]
Dementia
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Diabetes Mellitus, Type 2
A TLC bioautographic method for the detection of alpha- and beta-glucosidase inhibitors in plant extracts.
Dry Eye Syndromes
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease.
Enterocolitis, Necrotizing
Serum cytosolic beta-glucosidase activity in a rat model of necrotizing enterocolitis.
Epilepsies, Myoclonic
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Favism
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
Food Hypersensitivity
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.
Gangliosidosis, GM1
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
Gangliosidosis, GM1
Multiple carbohydrate-cleaving specificities in human acidic and neutral glycosidases.
Gaucher Disease
A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Gaucher Disease
Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test.
Gaucher Disease
Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
Gaucher Disease
Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Gaucher Disease
An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
Gaucher Disease
Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
Gaucher Disease
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
Gaucher Disease
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
Gaucher Disease
Beta-glucosidase activities in human tissues. Findings in Gaucher's disease.
Gaucher Disease
beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
Gaucher Disease
Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease.
Gaucher Disease
Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease.
Gaucher Disease
beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
Gaucher Disease
beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
Gaucher Disease
beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.
Gaucher Disease
Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
Gaucher Disease
Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
Gaucher Disease
Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N-(n-nonyl)Deoxynojirimycin.
Gaucher Disease
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
Gaucher Disease
Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
Gaucher Disease
Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Gaucher Disease
Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
Gaucher Disease
Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
Gaucher Disease
Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene".
Gaucher Disease
Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease.
Gaucher Disease
Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
Gaucher Disease
Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study.
Gaucher Disease
Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
Gaucher Disease
Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Gaucher Disease
Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages.
Gaucher Disease
Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
Gaucher Disease
Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Gaucher Disease
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy.
Gaucher Disease
Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
Gaucher Disease
Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
Gaucher Disease
Gaucher's disease type I. Report of a case with prominent deposition of ceroid in splenic endothelial cells and intestinal smooth muscle fibers.
Gaucher Disease
Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
Gaucher Disease
Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
Gaucher Disease
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Gaucher Disease
Genetic heterogeneity of membrane-bound beta-glucosidase in Gaucher's disease.
Gaucher Disease
Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease.
Gaucher Disease
Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
Gaucher Disease
Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
Gaucher Disease
Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Gaucher Disease
Identification of a feedback loop involving beta-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.
Gaucher Disease
Identity of beta-glucosidase, beta-xylosidase and one of the beta-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-beta-D-glycosides studies in cases of Gaucher's disease.
Gaucher Disease
Immunoquantification of beta-glucosidase: diagnosis and prediction of severity in Gaucher disease.
Gaucher Disease
Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches.
Gaucher Disease
In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.
Gaucher Disease
Isozymes of beta-glucosidase: determination of Gaucher's disease phenotypes.
Gaucher Disease
Leukocyte beta-glucosidase in a child with Gaucher's disease and his kinship.
Gaucher Disease
Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
Gaucher Disease
Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
Gaucher Disease
Modifications of the molecular weight of membrane-bound nonspecific beta-glucosidase in type 1 Gaucher disease determined in situ by the radiation inactivation method.
Gaucher Disease
Morphological and biochemical assessment of the cornea in a Gaucher disease carrier with keratoconus.
Gaucher Disease
Multiple carbohydrate-cleaving specificities in human acidic and neutral glycosidases.
Gaucher Disease
Multiple space-occupying lesions of the spleen in a case of Gaucher's disease.
Gaucher Disease
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Gaucher Disease
Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations.
Gaucher Disease
Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.
Gaucher Disease
N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Gaucher Disease
Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
Gaucher Disease
Prenatal diagnosis of Gaucher disease. Assay of the beta-glucosidase activity in amniotic fluid cells cultivated in two laboratories with different cultivation conditions.
Gaucher Disease
Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects.
Gaucher Disease
Properties of beta-glucosidase in cultured skin fibroblasts from controls and patients with Gaucher disease.
Gaucher Disease
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.
Gaucher Disease
Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Gaucher Disease
Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
Gaucher Disease
Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
Gaucher Disease
Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells.
Gaucher Disease
Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
Gaucher Disease
The cytosolic beta-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
Gaucher Disease
The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
Gaucher Disease
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
Gaucher Disease
The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
Gaucher Disease
The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
Gaucher Disease
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
Gaucher Disease
Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
Gaucher Disease
Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gaucher Disease
Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil.
Gaucher Disease
[Cavernoma complicated with biliopatia secondary to type 1 Gaucher disease: report of a Peruvian case].
Gaucher Disease
[Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination]
Gaucher Disease
[Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]
Gaucher Disease
[Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease]
Glioblastoma
Cyanide bystander effect of the linamarase/linamarin killer-suicide gene therapy system.
Glycogen Storage Disease Type II
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Graft vs Host Disease
Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
Hand, Foot and Mouth Disease
Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease.
Heart Failure
[Correction with cordaron of changes in beta-glucosidase activity induced by toxic effect of strophanthin K and simulated heart decompensation]
Herpes Zoster
Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida.
HIV Infections
A novel lectin from Pseudostellaria heterophylla roots with sequence simularity to Kunitz-type soybean trypsin inhibitor.
HIV Infections
Hypogin, a novel antifungal peptide from peanuts with sequence similarity to peanut allergen.
Hydrops Fetalis
Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects.
Hypersensitivity
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.
Infections
A lectin-like wheat gene responds systemically to attempted feeding by avirulent first-instar Hessian fly larvae.
Infections
Exoproteome Analysis of Human Pathogenic Dermatophyte Species and Identification of Immunoreactive Proteins.
Infections
Isolation and characterization of genes differentially expressed during the interaction between apple fruit and Penicillium expansum.
Infections
Sucrose-induced lupine defense against Fusarium oxysporum. Sucrose-stimulated accumulation of isoflavonoids as a defense response of lupine to Fusarium oxysporum.
Inflammatory Bowel Diseases
Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease.
Leukemia
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Leukemia
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Leukodystrophy, Metachromatic
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Lewy Body Disease
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Lipidoses
[Value of studying isoenzymes in hereditary lysosomal lipidoses. In particular beta-glucosidase (Gaucher's disease) and acid lipase (Wolman's disease and cholesterol ester storage disease)]
Lysosomal Storage Diseases
An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
Lysosomal Storage Diseases
Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.
Lysosomal Storage Diseases
Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches.
Lysosomal Storage Diseases
Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations.
Lysosomal Storage Diseases
Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility.
Lysosomal Storage Diseases
Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil.
Lysosomal Storage Diseases
[Screening methods for the diagnosis of lysosomal storage disease]
Malnutrition
Neonatal undernutrition and short term administration of hydrocortisone and thyroxine: effects on rat brain hydrolases.
Mannosidase Deficiency Diseases
Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.
Melanoma
beta-Glucosidase activity in fetal bovine serum renders the plant glucoside, hypoxoside, cytotoxic toward B16-F10-BL-6 mouse melanoma cells.
Melanoma
Morphological characterisation of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy.
Melanoma
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Mesothelioma
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.
Mesothelioma, Malignant
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.
Mouth Diseases
Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease.
Mucolipidoses
Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.
Mucolipidoses
Lysosomal enzymes in medium from cultured skin fibroblasts from normal individuals and patients with lysosomal diseases.
Mucopolysaccharidosis IV
An autophagic vacuolar myopathy-like disorder presenting as nonimmune hydrops in a female fetus.
Mycoses
Avenacosidase from oat: purification, sequence analysis and biochemical characterization of a new member of the BGA family of beta-glucosidases.
Mycoses
Novel type of enzyme multimerization enhances substrate affinity of oat beta-glucosidase.
Myeloproliferative Disorders
Platelet lysosomal enzymes are normal in myeloproliferative disorders.
Myocardial Infarction
Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats.
Myocardial Infarction
[Glycosphingolipid content and beta-galacto- and beta-glucosidase activity of the blood in acute myocardial infarction and postinfarction cardiosclerosis]
Myoclonic Epilepsies, Progressive
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Neoplasm Metastasis
Inhibition of experimental metastasis by an alpha-glucosidase inhibitor, 1,6-epi-cyclophellitol.
Neoplasms
Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors.
Neoplasms
Antitumor activity of methyl (5-fluoro-1H-2-oxo-4-pyrimidinyl beta-D-glucopyranosid)uronate against various experimental tumors.
Neoplasms
Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.
Neoplasms
Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.
Neoplasms
Enzyme activity profiles in mouse teratocarcinomas. A quantitative ultramicroscale analysis.
Neoplasms
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Neoplasms
Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats.
Neoplasms
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
Neoplasms
Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.
Neoplasms
[Tumour hyperacidulation through intravenous glucose infusion enhanced by amygdalin and beta-glucosidase application (author's transl)]
Nephrotic Syndrome
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Neurologic Manifestations
The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.
Niemann-Pick Diseases
Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseases.
Niemann-Pick Diseases
Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
Osteosarcoma
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Parkinson Disease
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Periodontitis
Glycosidase activities in gingival crevicular fluid in subjects with adult periodontitis or gingivitis.
Plant Diseases
Partial purification and properties of a beta-glucosidase from Erwinia herbicola Y46.
Rhinitis, Allergic, Seasonal
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.
Sarcoidosis
Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
Sarcoma
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Scabies
Deletion of bglC triggers a genetic compensation response by awakening the expression of alternative beta-glucosidase.
Scleroderma, Diffuse
Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis.
Shock, Septic
Application of cross-linked carboxymethyl cellulose degradation by beta-glucosidase and vaginal microbes to toxic shock syndrome.
Sphingolipidoses
Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
Sphingolipidoses
N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Starvation
A digestive beta-glucosidase from the silkworm, Bombyx mori: cDNA cloning, expression and enzymatic characterization.
Starvation
Exo-(1----3)-beta-glucanase, autolysin and trehalase activities during yeast growth and germ-tube formation in Candida albicans.
Starvation
Glycosyl hydrolases of cell wall are induced by sugar starvation in Arabidopsis.
Starvation
Isolation of cDNA clones of genes with altered expression levels in phosphate-starved Brassica nigra suspension cells.
Stupor
[Tumour hyperacidulation through intravenous glucose infusion enhanced by amygdalin and beta-glucosidase application (author's transl)]
Tuberculosis
[Evaluation of urease and beta-glucosidase activity for the practical identification of mycobacteria (author's transl)]
Uterine Cervical Neoplasms
Synthesis and biological activity of novel thiazolidin-4-ones with a carbohydrate moiety.
Vascular Diseases
Enzymes and cytomorphological sperm alterations in some diseases of the male reproductive system.
Wheat Hypersensitivity
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.
html completed